Role of extracellular matrix remodelling in adipose tissue pathophysiology. Relevance in the development of obesity

Histology and Histopathology

Volumn 27, Issue 12, 2012, Pages 1515-1528

  Catalán, Victoria ^a,b   Gómez Ambrosi, Javier ^a,b   Rodríguez, Amaia ^a,b   Frühbeck, Gema ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Adipose tissue; Angiogenesis; Collagens; Extracellular matrix; Hypoxia; Metalloproteinases

Indexed keywords

MATRIX METALLOPROTEINASE;

ADIPOSE TISSUE; ANIMAL; ANOXIA; BIOLOGICAL MODEL; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; LIPID METABOLISM; MACROPHAGE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN DEGRADATION; REVIEW; VASCULARIZATION;

ADIPOSE TISSUE; ANIMALS; ANOXIA; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; LIPID METABOLISM; MACROPHAGES; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; PROTEOLYSIS;

EID: 84871053603     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (175)

1. Adair-Kirk T.L. and Senior R.M. (2008). Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell. Biol. 40, 1101-1110.
2. Ahima R.S. (2006). Adipose tissue as an endocrine organ. Obesity 14, 242S-249S.
3. Alessi M.C., Poggi M. and Juhan-Vague I. (2007). Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr. Opin. Lipidol. 18, 240-245.
4. Apovian C.M. and Gokce N. (2012). Obesity and cardiovascular disease. Circulation 125, 1178-1182.
5. Arner E., Westermark P.O., Spalding K.L., Britton T., Ryden M., Frisen J., Bernard S. and Arner P. (2009). Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59, 105-109.
6. Balistreri C.R., Caruso C. and Candore G. (2010). The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. 2010, 802078.
7. Bastelica D., Morange P., Berthet B., Borghi H., Lacroix O., Grino M., Juhan-Vague I. and Alessi M.C. (2002). Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler. Thromb. Vasc. Biol. 22, 173-178.
8. Bays H.E., Gonzalez-Campoy J.M., Bray G.A., Kitabchi A.E., Bergman D.A., Schorr A.B., Rodbard H.W. and Henry R.R. (2008). Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev. Cardiovasc. Ther. 6, 343-368.
9. Björntorp P. (1974). Effects of age, sex, and clinical conditions on adipose tissue cellularity in man. Metabolism 23, 1091-1102.
10. Blüher M. (2010). The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr. Opin. Lipidol. 21, 38-43.
11. Bonanno E., Iurlaro M., Madri J.A. and Nicosia R.F. (2000). Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell Dev. Biol. Anim. 36, 336-340.
12. Bornstein P. (2001). Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107, 929-934.
13. Bouloumie A., Sengenes C., Portolan G., Galitzky J. and Lafontan M. (2001). Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50, 2080-2086.
14. Brakenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P. and Cao Y. (2004). Angiogenesis inhibitor, TNP-470, prevents dietinduced and genetic obesity in mice. Circ. Res. 94, 1579-1588.
15. Brekken R.A. and Sage E.H. (2000). SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol. 19, 569-580.
16. Calle E.E. and Kaaks R. (2004). Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591.
17. Cao Y. (2007). Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 117, 2362-2368.
18. Cao Y. (2010). Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat. Rev. Drug. Discov. 9, 107-115.
19. Carmeliet P. (2005). Angiogenesis in life, disease and medicine. Nature 438, 932-936.
20. Case D., Irwin D., Ivester C., Harral J., Morris K., Imamura M., Roedersheimer M., Patterson A., Carr M., Hagen M., Saavedra M., Crossno J. Jr, Young K.A., Dempsey E.C., Poirier F., West J. and Majka S. (2007). Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension. Am. J. Physiol. Lung. Cell. Mol. Physiol. 292, L154-164.
21. Catalán V., Gómez-Ambrosi J., Rodríguez A., Silva C., Rotellar F., Gil M.J., Cienfuegos J.A., Salvador J. and Frühbeck G. (2008). Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin. Endocrinol. 68, 213-219.
22. Catalán V., Gómez-Ambrosi J., Rodríguez A., Ramírez B., Silva C., Rotellar F., Gil M.J., Cienfuegos J.A., Salvador J. and Frühbeck G. (2009a). Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J. Mol. Med. 87, 803-813.
23. Catalán V., Gómez-Ambrosi J., Rodríguez A., Salvador J. and Frühbeck G. (2009b). Adipokines in the treatment of diabetes mellitus and obesity. Expert Opin. Pharmacother. 10, 239-254.
24. Catalán V., Gómez-Ambrosi J., Rodríguez A., Ramríez B., Rotellar F., Valenti V., Silva C., Gil M.J., Salvador J. and Frühbeck G. (2011a). Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass. J. Clin. Endocrinol. Metab. 96, 200-209.
25. Catalán V., Gómez-Ambrosi J., Rodríguez A., Ramírez B., Silva C., Rotellar F., Hernández-Lizoain J.L., Baixauli J., Valentí V., Pardo F., Salvador J. and Frühbeck G. (2011b). Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. J. Nutr. Biochem. 22, 634-641.
26. Chapman H.A., Riese R.J. and Shi G.P. (1997). Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59, 63-88.
27. Chavey C., Mari B., Monthouel M.N., Bonnafous S., Anglard P., Van Obberghen E. and Tartare-Deckert S. (2003). Matri x metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J. Biol. Chem. 278, 11888-11896.
28. Chiellini C., Costa M., Novelli S.E., Amri E.Z., Benzi L., Bertacca A., Cohen P., Del Prato S., Friedman J.M. and Maffei M. (2003). Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J. Cell. Physiol. 195, 309-321.
29. Cho C.H., Koh Y.J., Han J., Sung H.K., Jong Lee H., Morisada T., Schwendener R.A., Brekken R.A., Kang G., Oike Y., Choi T.S., Suda T., Yoo O.J. and Koh G.Y. (2007). Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ. Res. 100, e47-57.
30. Christiaens V. and Lijnen H.R. (2010). Angiogenesis and development of adipose tissue. Mol. Cell. Endocrinol. 318, 2-9.
31. Cinti S. (2001). The adipose organ: morphological perspectives of adipose tissues. Proc. Nutr. Soc. 60, 319-328.
32. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., Wang S., Fortier M., Greenberg A.S. and Obin M.S. (2005). Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355.
33. Crandall D.L., Hausman G.J. and Kral J.G. (1997). A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4, 211-232.
34. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., Ribeiro S.M., Lawler J., Hynes R.O., Boivin G.P. and Bouck N. (1998). Thrombospondin-1 is a major activator of TGF-ß1 in vivo. Cell 93, 1159-1170.
35. Croissandeau G., Chretien M. and Mbikay M. (2002). Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem. J. 364, 739-746.
36. Daquinag A.C., Zhang Y. and Kolonin M.G. (2011). Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol. Sci. 32, 300-307.
37. de Meijer V.E., Sverdlov D.Y., Le H.D., Popov Y. and Puder M. (2012). Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity. Hepatol. Res. 42, 601-610.
38. Derosa G., Ferrari I., D'Angelo A., Tinelli C., Salvadeo S.A., Ciccarelli L., Piccinni M.N., Gravina A., Ramondetti F., Maffioli P. and Cicero A.F. (2008). Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium 15, 219-224.
39. Di Girolamo N., Indoh I., Jackson N., Wakefield D., McNeil H.P., Yan W., Geczy C., Arm J.P. and Tedla N. (2006). Human mast cellderived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J. Immunol. 177, 2638-2650.
40. Divoux A. and Clément K. (2011). Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes. Rev. 12, e494-503.
41. Duca L., Blanchevoye C., Cantarelli B., Ghoneim C., Dedieu S., Delacoux F., Hornebeck W., Hinek A., Martiny L. and Debelle L. (2007). The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J. Biol. Chem. 282, 12484-12491.
42. Duncan R.E., Ahmadian M., Jaworski K., Sarkadi-Nagy E. and Sul H.S. (2007). Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 27, 79-101.
43. Fabbrini E., Magkos F., Mohammed B.S., Pietka T., Abumrad N.A., Patterson B.W., Okunade A. and Klein S. (2009). Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. USA 106, 15430-15435.
44. Fain J.N., Madan A.K., Hiler M.L., Cheema P. and Bahouth S.W. (2004). Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282.
45. Falanga V., Martin T.A., Takagi H., Kirsner R.S., Helfman T., Pardes J. and Ochoa M.S. (1993). Low oxygen tension increases mRNA levels of α 1 (I) procollagen in human dermal fibroblasts. J. Cell. Physiol. 157, 408-412.
46. Falanga V., Zhou L. and Yufit T. (2002). Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-ß1. J. Cell. Physiol. 191, 42-50.
47. Fichard A., Kleman J.P. and Ruggiero F. (1995). Another look at collagen V and XI molecules. Matrix Biol. 14, 515-531.
48. Flegal K.M., Carroll M.D., Kit B.K. and Ogden C.L. (2012). Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307, 491-497.
49. Fleischmann E., Kurz A., Niedermayr M., Schebesta K., Kimberger O., Sessler D.I., Kabon B. and Prager G. (2005). Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes. Surg. 15, 813-819.
50. Francki A., Bradshaw A.D., Bassuk J.A., Howe C.C., Couser W.G. and Sage E.H. (1999). SPARC regulates the expression of collagen type I and transforming growth factor-ß1 in mesangial cells. J. Biol. Chem. 274, 32145-32152.
51. Frühbeck G. (2004). The adipose tissue as a source of vasoactive factors. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2, 197-208.
52. Frühbeck G. (2005). Obesity: aquaporin enters the picture. Nature 438, 436-437.
53. Frühbeck G. (2006). The Sir David Cuthbertson Medal Lecture. Hunting for new pieces to the complex puzzle of obesity. Proc. Nutr. Soc. 65, 329-347.
54. Frühbeck G. (2008). Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol. Biol. 456, 1-22.
55. Frühbeck G. and Gómez-Ambrosi J. (2003). Control of body weight: a physiologic and transgenic perspective. Diabetologia 46, 143-172.
56. Frühbeck G., Alonso R., Marzo F. and Santidrian S. (1995). A modified method for the indirect quantitative analysis of phytate in foodstuffs. Anal. Biochem. 225, 206-212.
57. Frühbeck G., Gómez-Ambrosi J., Muruzábal F.J. and Burrell M.A. (2001). The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 280, E827-847.
58. Frühbeck G., Catalán V., Gómez-Ambrosi J. and Rodríguez A. (2006). Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. Trends Pharmacol. Sci. 27, 345-347.
59. Frühbeck G., López M. and Dieguez C. (2007). Role of caveolins in body weight and insulin resistance regulation. Trends Endocrinol. Metab. 18, 177-182.
60. Funicello M., Novelli M., Ragni M., Vottari T., Cocuzza C., Soriano- Lopez J., Chiellini C., Boschi F., Marzola P., Masiello P., Saftig P., Santini F., St-Jacques R., Desmarais S., Morin N., Mancini J., Percival M.D., Pinchera A. and Maffei M. (2007). Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores. PLoS One 2, e683.
61. Galic S., Oakhill J.S. and Steinberg G.R. (2009). Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 316, 129-139.
62. Geiger K., Leiherer A., Muendlein A., Stark N., Geller-Rhomberg S., Saely C.H., Wabitsch M., Fraunberger P. and Drexel H. (2011). Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis. PLoS One 6, e26465.
63. Gómez D.E., Alonso D.F., Yoshiji H. and Thorgeirsson U.P. (1997). Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol. 74, 111-122.
64. Gómez-Ambrosi J., Salvador J., Rotellar F., Silva C., Catalán V., Rodríguez A., Gil M. and Frühbeck G. (2006). Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes. Surg. 16, 262-269.
65. Gómez-Ambrosi J., Catalán V., Ramírez B., Rodríguez A., Colina I., Silva C., Rotellar F., Mugueta C., Gil M.J., Cienfuegos J.A., Salvador J. and Frühbeck G. (2007). Pl asma osteoponti n l evels and expression in adipose tissue are increased in obesity. J. Clin. Endocrinol. Metab. 92, 3719-3727.
66. Gómez-Ambrosi J., Catalán V., Rodríguez A., Ramírez B., Silva C., Gil M.J., Salvador J. and Frühbeck G. (2009). Involvement of serum vascul ar endothel i al growth factor fami l y members i n the development of obesity in mice and humans. J. Nutr. Biochem. 21, 774-780.
67. Gómez-Ambrosi J., Silva C., Galofré J.C., Escalada J., Santos S., Millán D., Vila N., Ibañez P., Gil M.J., Valentí V., Rotellar F., Ramírez B., Salvador J. and Frühbeck G. (2012). Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int. J. Obes. 36, 286-294.
68. Gregor M.F. and Hotamisligil G.S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445.
69. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., Wang Z.V., Landskroner-Eiger S., Dineen S., Magalang U.J., Brekken R.A. and Scherer P.E. (2009). Hypoxiainducible factor 1α induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 29, 4467-4483.
70. Halberg N., Wernstedt-Asterholm I. and Scherer P.E. (2008). The adipocyte as an endocrine cell. Endocrinol. Metab. Clin. North. Am. 37, 753-768.
71. Hardy O.T., Czech M.P. and Corvera S. (2012). What causes the insulin resistance underlying obesity? Curr. Opin. Endocrinol. Diabetes Obes. 19, 81-87.
72. Haslam D.W. and James W.P. (2005). Obesity. Lancet 366, 1197-1209.
73. Hausman D.B., DiGirolamo M., Bartness T.J., Hausman G.J. and Martin R.J. (2001). The biology of white adipocyte proliferation. Obes. Rev. 2, 239-254.
74. Heck L.W., Blackburn W.D., Irwin M.H. and Abrahamson D.R. (1990). Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am. J. Pathol. 136, 1267-1274.
75. Henegar C., Tordjman J., Achard V., Lacasa D., Cremer I., Guerre-Millo M., Poitou C., Basdevant A., Stich V., Viguerie N., Langin D., Bedossa P., Zucker J.D. and Clement K. (2008). Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 9, R14.
76. Higami Y., Barger J.L., Page G.P., Allison D.B., Smith S.R., Prolla T.A. and Weindruch R. (2006). Energy restriction lowers the expression of genes linked to inflammation, the cytoskeleton, the extracellular matrix, and angiogenesis in mouse adipose tissue. J. Nutr. 136, 343-352.
77. Hirsch J. and Batchelor B. (1976). Adipose tissue cellularity in human obesity. Clin. Endocrinol. Metab. 5, 299-311.
78. Hohenester E. and Engel J. (2002). Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 21, 115-128.
79. Horng T. and Hotamisligil G.S. (2011). Linking the inflammasome to obesity-related disease. Nat. Med. 17, 164-165.
80. Horton M.R., Shapiro S., Bao C., Lowenstein C.J. and Noble P.W. (1999). Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J. Immunol. 162, 4171-4176.
81. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M. and Shimomura I. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911.
82. Hu J.H., Du L., Chu T., Otsuka G., Dronadula N., Jaffe M., Gill S.E., Parks W.C. and Dichek D.A. (2010). Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice. Circulation 121, 1637-1644.
83. Huber J., Loffler M., Bilban M., Reimers M., Kadl A., Todoric J., Zeyda M., Geyeregger R., Schreiner M., Weichhart T., Leitinger N., Waldhausl W. and Stulnig T.M. (2007). Prevention of high-fat dietinduced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int. J. Obes. 31, 1004-1013.
84. Hunninghake G.W., Davidson J.M., Rennard S., Szapiel S., Gadek J.E. and Crystal R.G. (1981). Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science 212, 925-927.
85. Hynes R.O. (2009). The extracellular matrix: not just pretty fibrils. Science 326, 1216-1219.
86. Imai K., Hiramatsu A., Fukushima D., Pierschbacher M.D. and Okada Y. (1997). Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-ß1 release. Biochem. J. 322, 809-814.
87. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W. and Ratcliffe P.J. (2001). Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472.
88. Jean C., Gravelle P., Fournie J.J. and Laurent G. (2011). Influence of stress on extracellular matrix and integrin biology. Oncogene 30, 2697-2706.
89. Jones P.L. and Jones F.S. (2000). Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol. 19, 581-596.
90. Kahn S.E., Hull R.L. and Utzschneider K.M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846.
91. Karelis A.D. (2011). To be obese--does it matter if you are metabolically healthy? Nat. Rev. Endocrinol. 7, 699-700.
92. Keely S., Glover L.E., MacManus C.F., Campbell E.L., Scully M.M., Furuta G.T. and Colgan S.P. (2009). Selective induction of integrin ß1 by hypoxia-inducible factor: implications for wound healing. FASEB J. 23, 1338-1346.
93. Keophiphath M., Achard V., Henegar C., Rouault C., Clement K. and Lacasa D. (2009). Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol. Endocrinol. 23, 11-24.
94. Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N., Zhang B.B., Bonaldo P., Chua S. and Scherer P.E. (2009). Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 29, 1575-1591.
95. Koike T., Kimura N., Miyazaki K., Yabuta T., Kumamoto K., Takenoshita S., Chen J., Kobayashi M., Hosokawa M., Taniguchi A., Kojima T., Ishida N., Kawakita M., Yamamoto H., Takematsu H., Suzuki A., Kozutsumi Y. and Kannagi R. (2004). Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc. Natl. Acad. Sci. USA 101, 8132-8137.
96. Kolonin M.G., Saha P.K., Chan L., Pasqualini R. and Arap W. (2004). Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10, 625-632.
97. Korpos E., Wu C. and Sorokin L. (2009). Multipleroles of the extracellular matrix in inflammation. Curr. Pharm. Des. 15, 1349- 1357.
98. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R. and Ferrante A.W. Jr (2010). Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 120, 3466-3479.
99. Lang R.A. and Bishop J.M. (1993). Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74, 453-462.
100. Leask A. and Abraham D.J. (2004). TGF-ß signaling and the fibrotic response. FASEB J. 18, 816-827.
101. Ledoux S., Queguiner I., Msika S., Calderari S., Rufat P., Gasc J.M., Corvol P. and Larger E. (2008). Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 57, 3247-3257.
102. Lee M.J., Wu Y. and Fried S.K. (2010). Adipose tissue remodeling in pathophysiology of obesity. Curr. Opin. Clin. Nutr. Metab. Care 13, 371-376.
103. Li Y., Tong X., Rumala C., Clemons K. and Wang S. (2011). Thrombospondi n1 defi ci ency reduces obesi ty-associ ated inflammation and improves insulin sensitivity in a diet-induced obese mouse model. PLoS One 6, e26656.
104. Lijnen H.R. (2008). Angiogenesis and obesity. Cardiovasc. Res. 78, 286-293.
105. Lijnen H.R. (2009). Role of fibrinolysis in obesity and thrombosis. Thromb. Res. 123 Suppl 4, S46-49.
106. Liu L. and Meydani M. (2003). Angiogenesis inhibitors may regulate adiposity. Nutr. Rev. 61, 384-387.
107. Lolmede K., Durand De Saint Front V., Galitzky J., Lafontan M. and Bouloumie A. (2003). Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int. J. Obes. Relat. Metab. Disord. 27, 1187-1195.
108. Lumeng C.N., Bodzin J.L. and Saltiel A.R. (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184.
109. Lundgren M., Svensson M., Lindmark S., Renstrom F., Ruge T. and Eriksson J.W. (2007). Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia. Diabetologia. 50, 625-633.
110. Maquoi E., Munaut C., Colige A., Collen D. and Lijnen H.R. (2002). Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51, 1093-1101.
111. Mariman E.C. and Wang P. (2010). Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell. Mol. Life. Sci. 67, 1277-1292.
112. Marom B., Rahat M.A., Lahat N., Weiss-Cerem L., Kinarty A. and Bitterman H. (2007). Native and fragmented fibronectin oppositely modulate monocyte secretion of MMP-9. J. Leukoc. Biol. 81, 1466-1476.
113. Mazzatti D., Lim F.L., O'Hara A., Wood I.S. and Trayhurn P. (2012). A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes. Arch Physiol Biochem. 118, 112-120.
114. McCawley L.J. and Matrisian L.M. (2001). Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell. Biol. 13, 534-540.
115. Medrikova D., Jilkova Z.M., Bardova K., Janovska P., Rossmeisl M. and Kopecky J. (2012). Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. Int. J. Obes. 36, 262-272.
116. Messier V., Karelis A.D., Robillard M.E., Bellefeuille P., Brochu M., Lavoie J.M. and Rabasa-Lhoret R. (2009). Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 59, 20-24.
117. Midwood K.S., Hussenet T., Langlois B. and Orend G. (2011). Advances in tenascin-C biology. Cell 68, 3175-3199.
118. Milner R., Hung S., Erokwu B., Dore-Duffy P., LaManna J.C. and del Zoppo G.J. (2008). Increased expression of fibronectin and the α5 ß1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol. Cell. Neurosci. 38, 43-52.
119. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N. and Saito Y. (2003). Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46, 1483-1488.
120. Moore J.B. (2010). Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc. Nutr. Soc. 69, 211-220.
121. Morange P.E., Bastelica D., Bonzi M.F., Van Hoef B., Collen D., Juhan-Vague I. and Lijnen H.R. (2002). Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity. Thromb. Haemost. 87, 306-310.
122. Motamed K. (1999). SPARC (osteonectin/BM-40). Int. J. Biochem. Cell Biol. 31, 1363-1366.
123. Nakajima I., Muroya S., Tanabe R. and Chikuni K. (2002). Extracellular matrix development during differentiation into adipocytes with a unique increase in type V and VI collagen. Biol. Cell 94, 197-203.
124. Nakajima I., Yamaguchi T., Ozutsumi K. and Aso H. (1998). Adipose tissue extracellular matrix: newly organized by adipocytes during differentiation. Differentiation 63, 193-200.
125. Napolitano L. (1963). The Differentiation of White Adipose Cells. An Electron Microscope Study. J. Cell Biol. 18, 663-679.
126. Nishimura S., Manabe I., Nagasaki M., Hosoya Y., Yamashita H., Fujita H., Ohsugi M., Tobe K., Kadowaki T., Nagai R. and Sugiura S. (2007). Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56, 1517-1526.
127. Pasarica M., Gowronska-Kozak B., Burk D., Remedios I., Hymel D., Gimble J., Ravussin E., Bray G.A. and Smith S.R. (2009). Adipose tissue collagen VI in obesity. J. Clin. Endocrinol. Metab. 94, 5155-5162.
128. Pierleoni C., Verdenelli F., Castellucci M. and Cinti S. (1998). Fibronectins and basal lamina molecules expression in human subcutaneous white adipose tissue. Eur. J. Histochem. 42, 183-188.
129. Pipoly D.J. and Crouch E.C. (1987). Degradation of native type IV procollagen by human neutrophil elastase. Implications for l eukocyte-medi ated degradati on of basement membranes. Biochemistry 26, 5748-5754.
130. Planat-Benard V., Silvestre J.S., Cousin B., Andre M., Nibbelink M., Tamarat R., Clergue M., Manneville C., Saillan-Barreau C., Duriez M., Tedgui A., Levy B., Penicaud L. and Casteilla L. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109, 656-663.
131. Primeau V., Coderre L., Karelis A.D., Brochu M., Lavoie M.E., Messier V., Sladek R. and Rabasa-Lhoret R. (2011). Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. 35, 971-981.
132. Prins J.B. and O'Rahilly S. (1997). Regulation of adipose cell number in man. Clin. Sci. 92, 3-11.
133. Qiu Z., Dillen C., Hu J., Verbeke H., Struyf S., Van Damme J. and Opdenakker G. (2009). Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology 214, 835-842.
134. Rangaswami H., Bulbule A. and Kundu G.C. (2006). Osteopontin: role in cell signaling and cancer progression. Trends Cell. Biol. 16, 79-87.
135. Rausch M.E., Weisberg S., Vardhana P. and Tortoriello D.V. (2008). Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int. J. Obes. 32, 451-463.
136. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R. and Folkman M.J. (2002). Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. USA 99, 10730-10735.
137. Rutkowski J.M., Davis K.E. and Scherer P.E. (2009). Mechanisms of obesity and related pathologies: the macro- and microcirculation ofadipose tissue. FEBS J. 276, 5738-5746.
138. Scherer P.E., Bickel P.E., Kotler M. and Lodish H.F. (1998). Cloning of cell-specific secreted and surface proteins by subtractive antibody screening. Nat. Biotechnol. 16, 581-586.
139. Schipani E. (2010). Posttranslational modifications of collagens as targets of hypoxia and Hif-1α in endochondral bone development. Ann. NY Acad. Sci. 1192, 317-321.
140. Semenza G.L. (1999). Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell. Dev. Biol. 15, 551-578.
141. Senior R.M., Griffin G.L. and Mecham R.P. (1980). Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 66, 859-862.
142. Shao R., Hamel K., Petersen L., Cao Q.J., Arenas R.B., Bigelow C., Bentley B. and Yan W. (2009). YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene 28, 4456-4468.
143. Slater M. (1996). Dynamic interactions of the extracellular matrix. Histol. Histopathol. 11, 175-180.
144. Sorokin L. (2010). The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 10, 712-723.
145. Spencer M., Yao-Borengasser A., Unal R., Rasouli N., Gurley C.M., Zhu B., Peterson C.A. and Kern P.A. (2010). Adi pose ti ssue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am. J. Physiol. Endocrinol. Metab. 299, E1016-E1027.
146. Spencer M., Unal R., Zhu B., Rasouli N., McGehee R.E. Jr, Peterson C.A. and Kern P.A. (2011). Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J. Clin. Endocrinol. Metab. 96, E1990-1998.
147. Spiegelman B.M. and Farmer S.R. (1982). Decreases in tubulin and actin gene expression prior to morphological differentiation of 3T3 adipocytes. Cell 29, 53-60.
148. Spiegelman B.M. and Ginty C.A. (1983). Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell 35, 657-666.
149. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., Balletshofer B., Machicao F., Fritsche A. and Haring H.U. (2008). Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609-1616.
150. Sternlicht M.D. and Werb Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17, 463-516.
151. Strissel K.J., Stancheva Z., Miyoshi H., Perfield J.W. 2nd, DeFuria J., Jick Z., Greenberg A.S. and Obin M.S. (2007). Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56, 2910-2918.
152. Sun K., Kusminski C.M. and Scherer P.E. (2011). Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101.
153. Tang W., Zeve D., Suh J.M., Bosnakovski D., Kyba M., Hammer R.E., Tallquist M.D. and Graff J.M. (2008). White fat progenitor cells reside in the adipose vasculature. Science 322, 583-586.
154. Tartare-Deckert S., Chavey C., Monthouel M.N., Gautier N. and Van Obberghen E. (2001). The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J. Biol. Chem. 276, 22231-22237.
155. Trayhurn P. and Wood I.S. (2005). Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33, 1078-1081.
156. Ucuzian A.A., Gassman A.A., East A.T. and Greisler H.P. (2010). Molecular mediators of angiogenesis. J. Burn Care. Res. 31, 158-175.
157. Udalova I.A., Ruhmann M., Thomson S.J. and Midwood K.S. (2011). Expression and immune function of tenascin-C. Crit. Rev. Immunol. 31, 115-145.
158. Unal R., Yao-Borengasser A., Varma V., Rasouli N., Labbate C., Kern P.A. and Ranganathan G. (2010). Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. J. Clin. Endocrinol. Metab. 95, 2993-3001.
159. Varma V., Yao-Borengasser A., Bodles A.M., Rasouli N., Phanavanh B., Nolen G.T., Kern E.M., Nagarajan R., Spencer H.J. 3rd, Lee M.J., Fried S.K., McGehee R.E. Jr, Peterson C.A. and Kern P.A. (2008). Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 57, 432-439.
160. Ventura J.J., Cogswell P., Flavell R.A., Baldwin A.S. Jr and Davis R.J. (2004). JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev. 18, 2905-2915.
161. Virtue S. and Vidal-Puig A. (2010). Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. Biochim. Biophys. Acta 2010, 338-349.
162. Voros G., Maquoi E., Demeulemeester D., Clerx N., Collen D. and Lijnen H.R. (2005). Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146, 4545-4554.
163. Wang G.L. and Semenza G.L. (1995). Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237.
164. Weathington N.M., van Houwelingen A.H., Noerager B.D., Jackson P.L., Kraneveld A.D., Galin F.S., Folkerts G., Nijkamp F.P. and Blalock J.E. (2006). A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12, 317-323.
165. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L. and Ferrante A.W. Jr (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
166. Wellen K.E. and Hotamisligil G.S. (2003). Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112, 1785-1788.
167. Weyer C., Foley J.E., Bogardus C., Tataranni P.A. and Pratley R.E. (2000). Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43, 1498-1506.
168. Weyer C., Wolford J.K., Hanson R.L., Foley J.E., Tataranni P.A., Bogardus C. and Pratley R.E. (2001). Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol. Genet. Metab. 72, 231-238.
169. Woessner J.F. Jr (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154.
170. Wood I.S., de Heredia F.P., Wang B. and Trayhurn P. (2009). Cellular hypoxia and adipose tissue dysfunction in obesity. Proc. Nutr. Soc. 68, 370-377.
171. Wynn T.A. (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524-529.
172. Xiao Y., Junfeng H., Tianhong L., Lu W., Shulin C., Yu Z., Xiaohua L., Weixia J., Sheng Z., Yanyun G., Guo L. and Min L. (2006). Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity. J. Clin. Endocrinol. Metab. 91, 4520-4527.
173. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A. and Chen H. (2003). Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J. Clin. Invest. 112, 1821-1830
174. Yang M., Sun J., Zhang T., Liu J., Zhang J., Shi M.A., Darakhshan F., Guerre-Millo M., Clement K., Gelb B.D., Dolgnov G. and Shi G.P. (2008). Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler. Thromb. Vasc. Biol. 28, 2202-2208.
175. Ye J., Gao Z., Yin J. and He Q. (2007). Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 293, E1118-1128.